We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » 14th Annual FDA Inspections Summit Presentations
Email
Tweet

14th Annual FDA Inspections Summit Presentations

Annual FDA Inspections Summit

Click the session title to view the presentation.

SPEAKER BIOS   AGENDA PDF   AGENDA AT-A-GLANCE

PRE-CONFERENCE WORKSHOPS – Wednesday, Oct. 23, 2019

Drugs & Biologics Preconference Workshop

1:00 p.m. – 5:00 p.m.
Flawless FDA Inspection Handling and Response

  • John Avellanet, Managing Director and Principal, Cerulean Associates LLC

Clinical Trials Preconference Workshop

1:00 p.m. – 5:00 p.m.
ICH E6(R2): How to be Inspection Ready with Your Sponsor Risk Management Program

  • Susan Leister, VP, Quality & Compliance, Technical Resources International

Medical Devices Preconference Workshop

1:00 p.m. – 5:00 p.m.
Process Validation for Medical Devices: Preparing for a QSR Inspection

  • Dan O’Leary, President, Ombu Enterprises, LLC

 

DAY ONE – Thursday, Oct. 24, 2019

9:10 a.m. – 10:00 a.m.
FDA and D.C. Politics: A Look at FDA Achievements and What Lies Ahead

  • Marc Scheineson, Partner, Alston & Bird LLP

10:00 a.m. – 10:45 a.m.
Auditing Manufacturers: Linking Data Integrity with Quality Culture

  • Susan Schniepp, Fellow, Regulatory Compliance Associates, Inc.

 

Drugs & Biologics Track

11:10 a.m. – 12:00 p.m.
Concept of Operations: How Integration of the FDA Facility Evaluation and Inspection Program Impacts Your Organizations

  • John Taylor, President/Principal, Compliance and Regulatory Affairs, Greenleaf Health; former Acting Deputy Commissioner for Global
    Operations and Policy, FDA

12:00 p.m. – 12:45 p.m.
Audits, Inspections and Management of Suppliers in India and China

  • John McKay, CEO and Chief Compliance Officer, Q1 Associates LLC

1:45 p.m. – 3:15 p.m.
Panel Discussion: The US/EU Mutual Recognition Agreement (MRA) for Drug GMP Inspections

Moderator:

  • Cynthia Schnedar, Executive Vice President, Regulatory Compliance, Greenleaf Health; former Director, Office of Compliance, CDER, FDA

Panelists:

  • CPT Helen Saccone, Senior Advisor, Office of Strategic Programs, CDER, FDA
  • Chris Markus, Partner, King & Spalding

 

Clinical Trials Track

11:10 a.m. – 12:00 p.m.
Meeting CRO-Vendor Oversight Requirements

  • Liz Wool, President, Wool Consulting Group, Inc.

12:00 p.m. – 12:45 p.m.
Designing Data Integrity into Your Clinical Trials and Responding When an Issue Arises

  • Cynthia Schnedar, Executive Vice President, Regulatory Compliance, Greenleaf Health; former Director, Office of Compliance, CDER

1:45 p.m. – 2:45 p.m.
Quality by Design – Build Quality into Clinical Trials to Proactively Identify and Mitigate Risks

  • Sharon Reinhard, M.S., Executive Director, Merck Research Labs Quality Assurance, Merck & Co., Inc.

 

Medical Devices Track

11:05 a.m. – 11:55 a.m.
Preparing for a MDSAP Audit: A Case Study from the Manufacturer’s Perspective

  • Connie Hoy, Consultant, Hoy & Associates Regulatory Consulting

11:55 a.m. – 12:55 p.m.
Panel Discussion: EU-MDR: Final Push for Compliance by the May 26, 2020 Deadline

Moderator:

  • Brian Ludovico, Executive Director, NSF Medical Device Regulatory Certification

Panelists:

  • Karl Vahey, Vice President Manufacturing Quality, Cardinal Health
  • Dan O’Leary, President, Ombu Enterprises, LLC
  • Ibim Tariah, Vice President, EU MDR and IVDR Consulting Services, Regulatory & Quality Solutions (R&Q)

1:45 p.m. – 2:45 p.m.
FDA’s Shift from QSR to ISO 13485:2016: A Significant Change for Inspections

  • Kristen Grumet, Senior Vice President, Regulatory Compliance, Greenleaf Health; former FDA Field Investigator specializing in medical devices

 

PLENARY SESSION

3:00 p.m. – 4:30 p.m.
Panel Discussion: The 10 Best — and 10 Worst — Things to Do When FDA Staff Are on Site

  • Steve Niedelman, Lead Quality Systems and Compliance Consultant, King and Spalding, former FDA Deputy Associate Commissioner for Regulatory Operations
  • Susan Schniepp, Fellow, Regulatory Compliance Associates, Inc.
  • John McKay, CEO and Chief Compliance Officer, Q1 Associates LLC
  • David Elder, Executive Vice President, Greenleaf Health; former Director, Director, Office of Regional Operations, FDA

4:30 p.m. – 5:30 p.m.
Mock Inspection: Practice Makes Perfect

  • Steve Niedelman, Lead Quality Systems and Compliance Consultant, King and Spalding, former FDA Deputy Associate Commissioner for Regulatory Operations
  • David Elder, Executive Vice President, Greenleaf Health; former Director, Director, Office of Regional Operations, FDA
  • Steven Lynn, Principal GxP Consultant/Owner, Lynn Consulting; former Director, Office of Manufacturing and Product Quality, CDER, FDA
  • Kristen Grumet, Senior Vice President, Regulatory Compliance, Greenleaf Health; former FDA Field Investigator specializing in medical devices

 

DAY TWO – Friday, Oct. 25, 2019

9:10 a.m. – 10:00 a.m.
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

  • John Avellanet, Managing Director and Principal, Cerulean Associates LLC

10:00 a.m. – 10:45 a.m.
FDA 483 and Warning Letter Trends

  • Chalana Damron, Counsel, Crowell & Moring

11:00 a.m. – 12:00 p.m.
FDA’s Vision and Strategy for Field Programs (No Slides for This Session)

Moderator:

  • Steve Niedelman, Lead Quality Systems and Compliance Consultant, King and Spalding, former FDA Deputy Associate Commissioner for Regulatory Operations

Panelist:

  • Alonza Cruse, Director, Office of Pharmaceutical Quality Operations, ORA, FDA

 

 
 

FDAnews logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 – Fax (703) 538-7676 – Toll free (888) 838-5578

www.fdanews.com

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • Vaccine needle

    Turkish Researchers Downgrade Sinovac’s COVID-19 Vaccine Efficacy Rate

  • Luminex logo

    Luminex Receives EUA for Expanded Respiratory Pathogen Panel, Clearing It for COVID-19

  • Acquires -Acquired

    Amgen to Buy Five Prime Therapeutics for $1.9 Billion

  • abbott-logo.gif

    Abbott Secures EUA for COVID-19 Combination Test

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing